glp 1 coverage 2025 Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford US health agency unveils weight-loss

Weight loss journeys can feel overwhelming, especially when navigating medications

8-year trends in obesity, type 2 diabetes, and glucagon-like peptide-1 (GLP-1) use in patients with obstructive sleep apnea

Similarly, other subgroup analyses have explored the role of baseline cardiovascular risk as a potential effect modifier regarding the effect of treatment on MACE, HHF or kidney outcomes

More studies conducted with female rodent models and human subjects are needed to address these issues to ensure better maternal and fetal outcomes

The findings come from a new Translational Psychiatry study, while earlier reviews and clinical studies have also reported improvements in depressive symptoms among people taking GLP-1 receptor agonists